Can type VII collagen injections cure dystrophic epidermolysis bullosa?

Molecular Therapy

Volumn 17, Issue 1, 2009, Pages 6-7

  Bruckner Tuderman, Leena ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7;

BLISTER; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE THERAPY; HUMAN; KERATINOCYTE; NONHUMAN; NOTE; QUALITY OF LIFE; SCAR FORMATION; SKIN CANCER; SKIN FRAGILITY;

ANIMALS; BASEMENT MEMBRANE; COLLAGEN TYPE VII; EPIDERMOLYSIS BULLOSA DYSTROPHICA; HUMANS; INJECTIONS, INTRADERMAL; MICE; RECOMBINANT PROTEINS; SKIN;

EID: 58149242428     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.262     Document Type: Note

References (15)

1. Aumailley, M, Has, C, Tunggal, L and Bruckner-Tuderman, L (2006). Molecular basis of inherited skin-blistering disorders, and therapeutic implications. Expert Rev Mol Med 8: 1-21.
2. Mavilio, F, Pellegrini, G, Ferrari, S, Di Nunzio, F, Di Iorio, E, Recchia, A et al. (2006). Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12: 1397-1402.
3. Remington, J, Wang, X, Hou, Y, Zhou, H, Burnett, J, Muirhead, T et al. (2008). Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17: 26-33.
4. Fine, JD, Eady, RA, Bauer, EA, Bauer, JW, Bruckner-Tuderman, L, Heagerty, A et al. (2008). The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58: 931-950.
5. Fritsch, A, Loeckermann, S, Kern, JS, Braun, A, Bosl, MR, Bley, TA et al. (2008). A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118: 1669-1679.
6. Bruckner-Tuderman, L (1999). Biology of anchoring fibrils: Lessons from dystrophic epidermolysis bullosa. Matrix Biol 18, 43-54.
7. Kern, JS, Kohlhase, J, Bruckner-Tuderman, L and Has, C (2006). Expanding the COL7A1 mutation database: Novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 126: 1006-1012.
8. Heinonen, S, Mannikko, M, Klement, JF, Whitaker-Menezes, D, Murphy, GF and Uitto, J (1999). Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: A model for recessive dystrophic epidermolysis bullosa. J Cell Sci 112 3641-3648.
9. Baldeschi, C, Gache, Y, Rattenholl, A, Bouille, P, Danos, O, Ortonne, JP et al. (2003). Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet 12: 1897-1905.
10. Wong, T, Gammon, L, Liu, L, Mellerio, JE, Dopping-Hepenstal, PJ, Pacy, J, et al. (2008). Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128: 2179-2189.
11. Kadler, KE, Baldock, C, Bella, J and Boot-Handford, RP (2007). Collagens at a glance. J Cell Sci 120: 1955-1958.
12. Rattenholl, A, Pappano, WN, Koch, M, Keene, DR, Kadler, KE, Sasaki, T et al. (2002). Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J Biol Chem 277: 26372-26378.
13. Villone, D, Fritsch, A, Koch, M, Bruckner-Tuderman, L, Hansen, U and Bruckner, P (2008). Supramolecular interactions in the dermo-epidermal junction zone: Anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J Biol Chem 283: 24506-24513.
14. Sat, E, Leung, KH, Bruckner-Tuderman, L and Cheah, KS (2000). Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: Implications for gene therapy. Gene Ther 7: 1631-1639.
15. Sitaru, C, Mihai, S, Otto, C, Chiriac, MT, Haußer, I, Dotterweich, B et al. (2005). Induction of dermal-epidermal separation in mice by passive transfer of antibodies to type VII collagen. J Clin Invest 115: 870-878.